| Trial Name: |
Amyotrophic Lateral Sclerosis
|
| Intro: |
ALS is a devastating disease that eventually affects respiratory function. Treatment options for respiratory function are limited to no treatment, non-invasive or invasive ventilation. Stimulation of the Diaphragm in Amyotrophic Lateral Sclerosis is an investigation of a diaphragm pacing system |
| Condition: |
|
| Description: |
ALS is a devastating disease that eventually affects respiratory function. Treatment options for respiratory function are limited to no treatment, non-invasive or invasive ventilation. Stimulation of the Diaphragm in Amyotrophic Lateral Sclerosis is an investigation of a diaphragm pacing system. The ultimate goal is to determine whether providing electrical stimulation to the diaphragm muscle will maintain diaphragm muscle strength therefore, decreasing the rate of respiratory decline in ALS. This is a minimally invasive, low risk surgical procedure that laparoscopically implants electrodes into the diaphragm muscle. These electrodes are attached to a stimulator. The stimulator delivers electrical impulses to the diaphragm causing diaphragm contraction. |
| Criteria: |
Participants must be over 18 years of age, have a confirmed diagnosis of ALS, have no significant co-morbidities, and a Forced Vital Capacity (FVC) between 50-80% to enroll. |
| Contact: |
For information or to register for screening in this trial please call HealthMatch at (216) 844-5000, or complete and submit the form below. |
Participant Confidentiality:
All information regarding participation in Clinical Trials is treated with the
utmost confidentiality. University Hospitals Case Medical Center and the
Division of Clinical Research recognize and respect the confidentiality of this
information. Access to information related to clinical trials and their
participants is restricted to authorized clinical trials personnel only.
Back